Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06395571
Other study ID # P19-009
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 17, 2019
Est. completion date October 6, 2019

Study information

Verified date April 2024
Source Ausnutria Hyproca B.V.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to assess common gastrointestinal symptoms in healthy Brazilian infants receiving goat milk-based infant formula (GMF) compared to cow's milk-based infant formula (CMF) during a 24 week intervention.


Description:

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this double-blind, randomized controlled trial, gastrointestinal comfort in infants fed goat milk-based infant formula (GMF) or cow's milk-based infant formula (CMF) was studied. Fifty-six healthy infants aged 3-12 months were followed for 24 weeks. Stool consistency, regurgitation frequency and crying duration were measured weekly using an adapted version of the Cow's Milk-related Symptom Score (CoMiSSĀ®) where only the items for these scores were used. Blood hemoglobin levels were measured at the start and at the end of the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date October 6, 2019
Est. primary completion date October 6, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Months to 12 Months
Eligibility Inclusion Criteria: - gestational age 37-42 weeks - 3-12 months old at enrollment - should have consumed cow's milk-based products during the 48 hours prior to the baseline visit to exclude cow's milk allergic infants Exclusion Criteria: - metabolic or chronic disease or congenital malformation, serious concurrent illness that would interfere with study treatment, (i.e. sepsis, pneumonia with respiratory failure, cardiac failure) - infant's parent(s) or primary caregiver(s) diagnosed with major depression - infant's weight for length at baseline >|3| z-score indexes according to WHO criteria - infants enrolled in another interventional clinical research study - infants diagnosed with cow's milk allergies

Study Design


Intervention

Dietary Supplement:
Goat milk-based infant formula
Goat milk-based infant formula fed at age appropriate quantities for 24 weeks
Cow's milk-based infant formula
Cow's milk-based infant formula formula fed at age appropriate quantities for 24 weeks

Locations

Country Name City State
Brazil Daycare center Salvador Bahia

Sponsors (1)

Lead Sponsor Collaborator
Ausnutria Hyproca B.V.

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gastrointestinal symptoms Stool consistency, regurgitation frequency and crying duration as measured by an adapted Cow's Milk-related Symptom ScoreĀ®, where a higher score indicates more severe symptoms. 24 weeks, measured weekly
Secondary Blood hemoglobin levels Blood hemoglobin levels before and after intervention 24 weeks, measured at start and end
Secondary WHO z-score of weight-for-age Weight measured to the nearest 5.0 grams with clothes and diaper removed. 24 weeks, measured monthly
Secondary WHO z-score of length-for-age Body length without shoes, measured lying down to the nearest centimeter with a neonatometer. 24 weeks, measured monthly
Secondary WHO z-score of head circumference-for-age Head circumference measured with flexible non-stretching tape to the nearest centimeter. 24 weeks, measured monthly
Secondary WHO z-score of weight-for-length Weight and length measured as described above combined. 24 weeks, measured monthly
See also
  Status Clinical Trial Phase
Terminated NCT02541357 - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery N/A
Active, not recruiting NCT02358122 - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh N/A
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation NCT00943345 - Validation of New Tests for Gastrointestinal (GI) Permeability Phase 0
Completed NCT00612404 - Symptoms and Endoscopic Results in Consideration of Pretreatment N/A
Completed NCT01127711 - Cohort of Swedish Men N/A
Recruiting NCT05712525 - Gut Recovery In Patients Following Surgery
Recruiting NCT06094153 - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function N/A
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed NCT02486146 - GI Biorepository of Tissue and Bodily Fluids N/A
Completed NCT01816607 - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed NCT00247715 - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study) N/A
Completed NCT00035334 - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis Phase 2/Phase 3
Recruiting NCT06286865 - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial N/A
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT03725813 - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit N/A
Recruiting NCT05640401 - Holographic Screens as a Replacement of Monitors During GI Endoscopies N/A
Completed NCT02865564 - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics N/A
Completed NCT02651857 - Exploratory Study of Upper and Lower Endoscopic Fuse System N/A
Active, not recruiting NCT01984034 - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines N/A